Navigation Links
DURECT Announces Changes to its Board of Directors
Date:9/27/2013

">www.durect.com.

DURECT Forward-Looking Statement
The statements in this press release regarding POSIDUR and its PDUFA date in February 2014, and the potential market introduction of other products in the company's pipeline are forward-looking statements involving risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the risk of adverse decisions by regulatory agencies, including product non-approval, delays and additional costs due to requirements imposed by regulatory agencies, the risk that the FDA will not complete review of the POSIDUR NDA by the PDUFA date, potential adverse effects arising from additional testing or use of POSIDUR, the potential that the data that we have generated may not be deemed sufficient by FDA or other regulatory agencies to support regulatory approval of POSIDUR, our potential inability to license rights to POSIDUR on commercially acceptable terms, or at all, and the risk of obtaining marketplace acceptance of POSIDUR, avoiding infringing patents held by other parties and securing and defending patents of our own, and managing and obtaining capital to fund our growth, operations and expenses. Further information regarding these and other risks is included in DURECT's Form 10-Q on August 6, 2013 under the heading "Risk Factors."

NOTE: POSIDUR, SABER®, TRANSDUR®, and ELADUR are trademarks of DURECT Corporation. Remoxy, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
2. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
3. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
4. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
5. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
6. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
7. DURECT to Participate in Upcoming Healthcare Conferences
8. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
9. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
10. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
11. Trianni Announces Launch of Its Optimized Human Antibody Transgenic Mouse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... and SHANGHAI , Sept. 22, ... a global knowledge leader in healthcare technology, media ... support healthcare innovation in China ... health technologies. Continua and BHG announced this new ... held this week in Washington, DC ...
(Date:9/22/2014)... Md. , Sept. 22, 2014  Neuralstem, Inc. (NYSE ... MD, site investigator at Emory University, presented long-term follow ... human neural stem cells in the treatment of amyotrophic ... The presentation, which occurred at the Annual Symposium on ... Canada , on Friday, and was not open ...
(Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4
... CLEVELAND, Jan. 27, 2012 Neurodevice ... million Series B investment round led ... December 2011, and secured non-dilutive funding ... $1.065 million Innovation Ohio loan and ...
... 27, 2012 Medical Alarm Concepts Holding, Inc. (OTCQB: ... alarm system that allows the user to speak and ... schedule for this week,s media test.   ... Hallmark, Inspirational TV, Fox News Channel, and MSNBC. The ...
Cached Medicine Technology:Neurodevice Firm Checkpoint Surgical Raises $3M 2Medical Alarm Concepts and Harrington Media Announce Final Schedule for MediPendantâ„¢ Nationwide Television Test Launch 2
(Date:9/22/2014)... CA (PRWEB) September 22, 2014 ... treatment for patients who require orthodontic work. Six-Month Smiles ... smile they deserve in a fast and effective way. ... to be extremely daunting. Having to wear metal braces ... certain foods and spend time keeping the braces clean, ...
(Date:9/22/2014)... exercise more and drink more , Study used smartphones ... Findings differ from past research on physical activity and ... finds that on days when people exercise more -- ... too. , This is the only study to use ... physical activity and alcohol use. , "Monday through Wednesday ...
(Date:9/22/2014)... new study pulls back the curtain on one of ... payment and income between physicians who perform operations, procedures ... to perception, the research indicates, the physician payment system ... procedure-performing doctors. , The new findings counter the widely ... minute explains why doctors who perform procedures often earn ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... children aged 6 months and older be vaccinated for the ... their influenza vaccine recommendations to advise that the youngest kids ... The AAP also wants parents of children aged 2 to ... instead of the flu shot if it,s readily available. ...
(Date:9/22/2014)... New York Malaysia today became a founding partner ... dollar initiative dedicated to promoting young talent in science, ... Led by the New York Academy of Sciences (NYAS), ... at UN Headquarters Monday Sept. 22. , With the ... more than 100 countries by 2020, the initiative will ...
Breaking Medicine News(10 mins):Health News:Starbrite Dental Introduces Six-Month Smiles 2Health News:We drink more alcohol on gym days 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3
... strongly propose that diabetes newly diagnosed in people above ... pancreatic cancer.// Older patients whose diabetes began late in ... with pancreatic cancer within three years following onset of ... people in their 70s when diabetes first appeared. ...
... men are putting their lives at risk because they fail ... embarrassed to consult their general practitioner if they feel a ... case study involving a young man who was involved ... days later he died of a blood clot in the ...
... The functioning of stem cells has an outstanding nature. Initially, ... cells, promising repair of damaged lung tissue. The potential of ... more specialised cells - is now well established.// Researchers at ... first creation of lung cells from stem cells in mice. ...
... at the Hopkins University, working with yeast have ... the replication of HIV inside cells, a finding that ... for the virus that causes AIDS.//,A team of researchers ... virus depends on an enzyme called reverse transcriptase to ...
... new study taking cholesterol-lowering drugs called 'statins' could elevate ... research has shown the benefits of statins, drugs that ... that the drugs might// increase their risk of peripheral ... in the hands and feet. ,The research team ...
... hearing loss are going down well with those who use ... aged over 60 in the United States. Traditionally there was ... acoustic hearing aid. // ,Now, however, there's another choice ... the surrounding bones. Researchers in the US have surveyed 100 ...
Cached Medicine News:Health News:Pancreatic Cancer may be linked to Diabetes 2Health News:Patients with testicular cancer dying through unfamiliarity 2Health News:Elevating Manganese Levels hold back HIV 2
... Human Insulin-like growth factor binding protein-2 ... (further IGFBPs have been proposed) which specifically ... and IGF-II. The binding affinity of IGFBP-2 ... higher than for IGF-I [1], suggesting a ...
... Insulin-like growth factor binding protein-2 (IGFBP-2) is ... have been proposed) which specifically bind and ... The binding affinity of IGFBP-2 for IGF-II ... for IGF-I [1], suggesting a role in ...
... Androstenedione, produced in the adrenal gland and ... testosterone and estrone, both of which may ... relatively weak androgenic activity, estimated at ~(less ... [1]. However, serum androstenedione levels often exceed ...
... proteins that suppress the secretion of FSH ... consists of two distinct chains, or subunits ... consists of the alpha-subunit and betaA-subunit. Inhibin ... Only the dimeric forms of the molecule, ...
Medicine Products: